Xeris Biopharma Holdings (XERS) Goodwill (2021 - 2025)
Historic Goodwill for Xeris Biopharma Holdings (XERS) over the last 5 years, with Q3 2025 value amounting to $22.9 million.
- Xeris Biopharma Holdings' Goodwill changed 0.0% to $22.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.9 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $22.9 million for FY2024, which is 0.0% changed from last year.
- As of Q3 2025, Xeris Biopharma Holdings' Goodwill stood at $22.9 million, which was down 0.0% from $22.9 million recorded in Q2 2025.
- In the past 5 years, Xeris Biopharma Holdings' Goodwill registered a high of $22.9 million during Q4 2021, and its lowest value of $22.9 million during Q4 2021.
- Over the past 5 years, Xeris Biopharma Holdings' median Goodwill value was $22.9 million (recorded in 2021), while the average stood at $22.9 million.
- Within the past 5 years, the most significant YoY rise in Xeris Biopharma Holdings' Goodwill was 0.0% (2022), while the steepest drop was 0.0% (2022).
- Over the past 5 years, Xeris Biopharma Holdings' Goodwill (Quarter) stood at $22.9 million in 2021, then changed by 0.0% to $22.9 million in 2022, then changed by 0.0% to $22.9 million in 2023, then changed by 0.0% to $22.9 million in 2024, then changed by 0.0% to $22.9 million in 2025.
- Its Goodwill was $22.9 million in Q3 2025, compared to $22.9 million in Q2 2025 and $22.9 million in Q1 2025.